Nonoperative treatment of metatarsophalangeal joint synovitis

Foot Ankle Int. 1995 Dec;16(12):771-7. doi: 10.1177/107110079501601206.

Abstract

The results of nonoperative treatment of metatarsophalangeal (MP) joint synovitis in 13 patients without known rheumatologic conditions (15 joints) were reviewed. Average duration of forefoot pain was 4 +/- 3 months (range 0.5-12 months), except for one patient who had pain for 30 months. The second MP joint was involved in nine cases (60%), and the third was involved in six cases (40%). Examination revealed tenderness and palpable fullness of the MP joint in all cases; painful dorsal drawer sign was present in 10 cases (67%), adjacent interdigital tenderness in six cases (40%), and hammertoe deformity in eight cases (53%). Treatment included intra-articular corticosteroid injection and rocker-sole show modification to limit MP joint dorsiflexion. At follow-up evaluation (18 +/- 9 months, range 4-26 months), the involved MP joint was asymptomatic in nine joints (60%), improved or almost asymptomatic in five joints (33%), and operated in one (7%) joint. Two of seven (29%) joints not initially associated with hammertoe developed a mild hammertoe deformity from time of diagnosis to follow-up. In conclusion, nonoperative treatment can be effective for MP joint synovitis, and the incidence of progressive hammertoe deformity in successfully treated cases is low.

MeSH terms

  • Adult
  • Aged
  • Bupivacaine / administration & dosage*
  • Combined Modality Therapy
  • Dexamethasone / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Intra-Articular
  • Lidocaine / administration & dosage*
  • Male
  • Metatarsophalangeal Joint* / diagnostic imaging
  • Metatarsophalangeal Joint* / physiopathology
  • Middle Aged
  • Pain Measurement
  • Radiography
  • Range of Motion, Articular / drug effects
  • Shoes*
  • Synovitis / diagnostic imaging
  • Synovitis / physiopathology
  • Synovitis / rehabilitation*
  • Treatment Outcome
  • Triamcinolone / administration & dosage*

Substances

  • Triamcinolone
  • Dexamethasone
  • Lidocaine
  • Bupivacaine